Iteratively Designed Phospholipid-Targeted Supramolecular Sonosensitizers for Precision Treatment of Pulmonary Infections
Journal of the American Chemical Society · 02.09.2026 · 148 (34) · 36969-36982
DOI: 10.1021/jacs.6c10086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 18.08.2026. Verfasst von Qian Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Central China Normal University, Wuhan430079, China. Hauptthemen laut MEDLINE: Phospholipids, Antifungal Agents, Candidiasis, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Fungal infections represent a significant global health threat, exacerbated by the scarcity of new therapeutic options, increasing drug resistance, and host toxicity. Sonodynamic therapy (SDT) offers a promising approach to overcoming antimicrobial resistance by enabling the localized generation of cytotoxic reactive oxygen species (ROS) within deep-seated lesions. Nevertheless, reports of SDT for in vivo antifungal treatment remain scarce, largely due to suboptimal ROS generation efficiency, poor biofilm penetration, and a lack of fungal specificity. Herein, we report the iterative design of RuB-C12, a phospholipid-targeted supramolecular sonosensitizer assembled via molecular engineering of ligand and acceptor building blocks into a Ru(II) metallocycle. Upon ultrasound activation, RuB-C12 markedly enhances ROS production while simultaneously improving the fungal membrane affinity and biofilm penetration. Mechanistic studies reveal that RuB-C12 effectively eradicates pathogenic yeasts by disrupting phospholipid phase transitions and perturbing intracellular redox homeostasis. Notably, RuB-C12 demonstrates a superior selectivity index (SI = 10–20) toward mammalian cells compared with the clinically approved amphotericin B (SI < 5). In murine models of wound and pulmonary Candida albicans infections as well as in clinical specimens, RuB-C12-mediated SDT significantly reduces fungal burden without inducing observable systemic toxicity. Collectively, this work highlights host–pathogen lipid disparity as a promising paradigm for developing precision antifungal strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry, Central China Normal University, Wuhan430079, China.
- National Key Laboratory of Agricultural Microbiology, College of Biomedicine and Health, Huazhong Agricultural University, Wuhan430070, China.
- Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan430071, China.
- Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, China.
- Hubei Jiangxia Laboratory, Wuhan430020, China.
ORCID-Profile: Junrong Li, Yao Sun
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Fundamental Research Funds for the Central Universities
- State Key Laboratory of Green Pesticide
Zitieren
APA
Li, Q., Pang, Y., Zhang, J., Liu, Y., Chen, H., Wang, Y., Mei, L., Tu, L., Li, J., & Sun, Y. (2026). Iteratively Designed Phospholipid-Targeted Supramolecular Sonosensitizers for Precision Treatment of Pulmonary Infections. Journal of the American Chemical Society, 148(34), 36969-36982. https://doi.org/10.1021/jacs.6c10086
Vancouver
Li Q, Pang Y, Zhang J, Liu Y, Chen H, Wang Y, et al. Iteratively Designed Phospholipid-Targeted Supramolecular Sonosensitizers for Precision Treatment of Pulmonary Infections. Journal of the American Chemical Society. 2026;148(34):36969-36982. doi:10.1021/jacs.6c10086
BibTeX
@article{Li2026,
author = {Li, Qian and Pang, Yida and Zhang, Junhua and Liu, Yanping and Chen, Hui and Wang, Yuting and Mei, Longcan and Tu, Le and Li, Junrong and Sun, Yao},
title = {Iteratively Designed Phospholipid-Targeted Supramolecular Sonosensitizers for Precision Treatment of Pulmonary Infections},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {34},
pages = {36969--36982},
doi = {10.1021/jacs.6c10086}
}
EUVIMED